Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX) — widely prescribed for urinary tract infections — are at increased risk of elevated potassium levels, called hyperkalemia, according to a new study.
Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX) — widely prescribed for urinary tract infections — are at increased risk of elevated potassium levels, called hyperkalemia, according to a new study.